Fennec Pharmaceuticals Inc

NASDAQ:FENC   4:00:00 PM EDT
9.54
-0.03 (-0.31%)
Earnings Announcements

Fennec Pharmaceuticals Reports Q3 Loss Of $0.31 Per Share

Published: 11/11/2022 12:20 GMT
Fennec Pharmaceuticals Inc (FENC) - Fennec Pharmaceuticals Announces Third Quarter 2022 Financial Results and Provides Business Update.
Qtrly Loss per Share $0.31.
Cash and Cash Equivalents Were $29.8 Million at September 30, 2022.
Q3 Earnings per Share View $-0.18 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.8 Million
Adjusted EPS is expected to be -$0.26

Next Quarter Revenue Guidance is expected to be $3.05 Million
Next Quarter EPS Guidance is expected to be -$0.16

More details on our Analysts Page.